“At Deloitte, we selected Digistain® from nearly 300 global start-ups as one of the top 5 most innovative companies in our Health & BioTech Accelerator programme. This AI-powered precision diagnostic tool brings much-needed efficiency and lower acquisition costs to the field of oncology. We have seen high interest from some of the largest private payors and world-class healthcare providers in Italy, drawn by Digistain’s unique ability to reduce healthcare costs while also easing the anxiety patients face as they await results — sometimes for weeks. It is a truly elegant and ingenious invention, and exactly the kind of innovation that will revolutionise modern healthcare.”
— Deloitte Health & BioTech Accelerator
Digistain Launches First International Lab in South Africa
In our ongoing effort to bring accessible cancer diagnostics to the regions that need them most, we are proud to announce the official launch of
